Last reviewed · How we verify
NCT06101407
Univent Tube for Thoracoscopic Thymectomy in Myasthenic Patients
trial in Myasthenia Gravis in 83 participants. Completed in 25 December 2019.
20 December 2019
Quick facts
| Lead sponsor | Nguyen Dang Thu |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 83 |
| Start date | 15 January 2016 |
| Primary completion | 20 December 2019 |
| Estimated completion | 25 December 2019 |
Conditions studied
- Myasthenia Gravis — all drugs for Myasthenia Gravis →
Sponsor
Nguyen Dang Thu
Who can join
Adults 15 to 80, any sex, with Myasthenia Gravis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational study included consecutive MG patients who underwent thoracoscopic thymectomy with Univent tube intubation under general anesthesia without NMBAs and combined with airway topical anesthesia between January 2016 and December 2019. The investigators focus on intubation conditions, surgical conditions, intraoperative respiratory, and airway complications
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Univent tube for thoracoscopic thymectomy in myasthenic patients anesthetized without neuromuscular blocking agents: An observational study.
Hien VV, Tu NH, Thu ND. · · 2025 · PMID 40642632 · DOI 10.4103/sja.sja_580_24
Verify or expand the search:
- PubMed search for NCT06101407
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myasthenia Gravis
Currently open trials in the same condition.
- NCT07478172 — Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease · NA · recruiting
- NCT07217587 — Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis · Phase 3 · recruiting
- NCT07284420 — ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With · Phase 2 · recruiting
- NCT07294170 — ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Particip · recruiting
- NCT07246564 — Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myastheni · Phase 4 · recruiting
Other Nguyen Dang Thu trials
Trials by the same sponsor.
- NCT07313644 — EIT-Guided PEEP Optimization in Trauma and Postoperative ARDS · NA · recruiting
- NCT06850844 — Recruitment Maneuvers and PEEP-guided Electrical Impedance Tomography for Abdominal Laparoscopic Surgery Patients · NA · recruiting
- NCT06879600 — High-Flow Nasal Oxygen for Preoxygenation in Emergency Surgery Patients With Full Stomachs · NA · recruiting
- NCT06260826 — CPAP on Oxygenation and Pulmonary Function in Elderly Patients After Major Open Abdominal Surgery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06101407 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nguyen Dang Thu
- Last refreshed: 26 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06101407.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing